JP2024536600A5 - - Google Patents

Info

Publication number
JP2024536600A5
JP2024536600A5 JP2024524385A JP2024524385A JP2024536600A5 JP 2024536600 A5 JP2024536600 A5 JP 2024536600A5 JP 2024524385 A JP2024524385 A JP 2024524385A JP 2024524385 A JP2024524385 A JP 2024524385A JP 2024536600 A5 JP2024536600 A5 JP 2024536600A5
Authority
JP
Japan
Prior art keywords
vaccine
iav
antigen
use according
αrp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024524385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/079532 external-priority patent/WO2023072805A1/en
Publication of JP2024536600A publication Critical patent/JP2024536600A/ja
Publication of JP2024536600A5 publication Critical patent/JP2024536600A5/ja
Pending legal-status Critical Current

Links

JP2024524385A 2021-10-25 2022-10-24 ブタａ型インフルエンザウイルス感染に対して子ブタを防御するためのワクチン Pending JP2024536600A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21204364 2021-10-25
EP21204364.0 2021-10-25
PCT/EP2022/079532 WO2023072805A1 (en) 2021-10-25 2022-10-24 A vaccine for the protection of piglets against swine influenza a virus infection

Publications (2)

Publication Number Publication Date
JP2024536600A JP2024536600A (ja) 2024-10-04
JP2024536600A5 true JP2024536600A5 (https=) 2025-10-24

Family

ID=78617136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024524385A Pending JP2024536600A (ja) 2021-10-25 2022-10-24 ブタａ型インフルエンザウイルス感染に対して子ブタを防御するためのワクチン

Country Status (5)

Country Link
US (1) US20250281597A1 (https=)
EP (1) EP4422678A1 (https=)
JP (1) JP2024536600A (https=)
CN (1) CN118139640A (https=)
WO (1) WO2023072805A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4168429A1 (en) * 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
CN1989250B (zh) 2004-05-18 2013-11-20 阿尔法瓦克斯公司 Tc-83衍生的甲病毒属载体、颗粒和方法
US8460913B2 (en) 2007-06-21 2013-06-11 Alpha Vax, Inc. Promoterless cassettes for expression of alpha virus structural proteins
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US20180326040A1 (en) * 2015-11-16 2018-11-15 Kansas State University Research Foundation Influenza virus vaccine and vaccine platform
EP3558351B1 (en) 2016-12-23 2022-01-26 Intervet International B.V. Combination vaccine for swine
MX2020005584A (es) 2017-12-04 2020-09-14 Intervet Int Bv Vacunacion con particulas de replicon y adyuvante oleoso.
WO2019121513A1 (en) 2017-12-18 2019-06-27 Intervet International B.V. Swine influenza a virus vaccine
BR112022025678A2 (pt) * 2020-06-19 2023-01-17 Intervet Int Bv Vacina contra o vírus da influenza a suína compreendendo duas partículas de replicon de rna distintas

Similar Documents

Publication Publication Date Title
TWI711462B (zh) 二價豬流感病毒疫苗
US11103569B2 (en) Vaccine for protection against Streptococcus suis
JP2013518052A5 (https=)
Opriessnig et al. Future perspectives on swine viral vaccines: where are we headed?
US11696944B2 (en) Vaccine for protection against Streptococcus suis
EP3549600B1 (en) A vaccine for protection against streptococcus suis
JP2024536600A5 (https=)
Jones et al. A nasal Proteosome™ influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity
Zhao et al. Analysis of efficacy obtained with a trivalent inactivated Haemophilus parasuis serovars 4, 5, and 12 vaccine and commercial vaccines against Glässer’s disease in piglets
Choe et al. Efficacy of orally administered porcine epidemic diarrhea vaccine-loaded hydroxypropyl methylcellulose phthalate microspheres and RANKL-secreting L. lactis
US12295999B2 (en) Vaccine for protection against Streptococcus suis
CN105873604B (zh) 针对prrs和胞内劳森氏菌的猪疫苗
Xu et al. Evaluation of a chimeric multi-epitope-based DNA vaccine against subgroup J avian leukosis virus in chickens
EP2454374B1 (en) Oral vaccines produced and administered using edible micro-organism
JP2024520730A5 (https=)
US9913896B2 (en) Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)
AU2025201124A1 (en) Methods and uses of a serum composition for preventing or treating mucosa-related infectious disease in young mammals
CN101300027B (zh) 分泌性IgA和IgG抗体诱导剂
Cuevas-Romero et al. Immunogenicity of a recombinant hemagglutinin neuraminidase-Porcine rubulavirus produced by Escherichia coli of Porcine rubulavirus gives protective immunity of litter after challenge
RU2024113858A (ru) Вакцина для защиты поросят от инфекции, вызываемой вирусом свиного гриппа а
Yang et al. Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
JP7349366B2 (ja) クロストリジウム類毒素を含むワクチン
Shibuya et al. Nasal–subcutaneous prime–boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections
CUEVAS-ROMERO et al. Immunogenicity of a recombinant HN-PorPV produced by E. coli of Porcine rubulavirus gives protective immunity of litter after challenge
Plysup et al. Co-immunization with recombinant S5196–272 and S6200–317 proteins for enhanced protective antibody response against Tilapia lake virus in Nile tilapia, Oreochromis niloticus (Linnaeus, 1758)